H-1B sponsorship profile: PTC Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, PTC Therapeutics, Inc filed 35 Labor Condition Applications covering 46 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (35 certified of 35 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on PTC Therapeutics, Inc’s H-1B petitions range from $68,000 at the low end to $294,085 at the high end, with a petition-weighted average of $120,871. That range reflects the mix of occupations the company sponsors, led by Associate Scientist I, Quality Control (GMP Testing) (4 petitions at $76,390 avg), followed by Sr. Scientist, Analytical Development and Sr. Manager., Financial Systems and Consolidations CoE . H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. PTC Therapeutics, Inc is headquartered in South Plainfield, NJ under NAICS code 3254, and places H-1B workers across 8 states, most heavily in NJ, CA, KS. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where PTC Therapeutics, Inc ranks. By H-1B petition volume, PTC Therapeutics, Inc is #6,461 of 119,880 employers nationally and #632 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.